The American Diabetes Association (ADA) updates diabetes care standardsby 2025.These new recommendations are very important for all of us who live with diabetes, since they help us better handle our condition and improve our quality of life.
1. Time in Objective Range for older adults with MCG for those of you who use continuous glucose (MCG) monitors, the ADA recommends that you pass at least 50% of the time (about 12 hours a day) in the target range of 70–180 mg/dl.In addition, the time in hypoglycemia (& lt values; 70 mg/dl) must not exceed 1% of the day (about 15 minutes).
2. Type 2 diabetes and fat liver disease If you have type 2 diabetes and non-alcoholic fatty liver disease (EHGNA) or non-alcoholic stoatititis (EHNA), the use of GLP-1 agonists or dual agonists of GIP/LPG is now recommended-1 for glycemic control and weight loss.In case of liver fibrosis risk, pioglitazone or LPG-1/GIP agonists are preferred, and the combination of both can be considered.
3. Physical activity and sedentary time It is crucial to interrupt the position sitting at least every 30 minutes to improve glycemic control.In addition, both adults and young people who receive medications for weight control or metabolic surgery should follow physical activity recommendations to avoid loss of muscle mass.
4. Type 1 diabetes and use of recreational cannabis The ada advises the use of recreational cannabis in people with type 1 diabetes due to the risk of cannabinoid hyperemes syndrome, which causes severe and persistent vomiting.
5. Insulin management The medication and insulin costs tables have been updated and reference to basal insulin & GT doses has been eliminated;0.5 U/kg/day as an overbass indication.Now the glycemic variability and episodes of hypoglycemia are considered.
6. New recommendations for children and adolescents Insulin bombs should be offered to all children and adolescents with type 1 diabetes who can use them safely.The nutritional principles with specific examples of healthy and non -healthy foods have also been updated.
7. Diabetes in hospitalized and critical patients for those who are hospitalized, glycemic objectives are 140–180 mg/dl in critical patients and 100–180 mg/dl in non -critical patients.The use of intravenous insulin infusion is recommended to achieve these objectives and avoid hypoglycemia.
8. Prevention and management of heart failure People with type 2 diabetes, obesity and symptomatic heart failure can benefit from a GLP-1 agonist to improve symptoms and physical capacity.
These updates reflect a more individualized approach, with emphasis on technology, advanced pharmacological therapies and the prevention of complications.The most relevant to us is the attention to the times in rank, the reduction of sedentary time and the promotion of technologies such as continuous glucose monitors and insulin bombs.
I hope this information is useful.
